As shown in Fig. 2A and B, we successfully constructed organoids derived from the patient’s tumor samples, which expressed tumor-specific markers MUC-1 and IMP-3, as well as the proliferation marker KI-67 (Fig. 2C). Here, IMP3 is linked to neoplasm.